Macada Holding, Inc. Announces Its Subsidiary Lyfetec, Inc. Has Signed a Purchase Agreement for Three Medical Formulas With a Ge
26 April 2010 - 10:30PM
Marketwired
Macada Holding
, Inc. (PINKSHEETS: MCDA)
announced that its subsidiary Lyfetec, Inc. has signed a purchase
agreement for three medical treatment formulas and the rights to
patent all three formulas in the United States under the Lyfetec
name.
Dr. Karsten Klingellioller, a bio-chemist, created these three
skin disease treatment products. Dr. Kingellioller, who presently
holds four doctors degrees, has completed U.S. and European
clinical trials and patents on a variety of cancer and skin
products throughout his career.
The formulas acquired by Lyfetec, Inc. have anti-aging and skin
cell rejuvenation additives that have been added for Lyfetec's new
Bio-Skin product line. Before Lyfetec's request to add anti-aging
and skin cell rejuvenation additives, Dr. Karsten's formulas meet
FDA and CE safety standards to treat melanoma - neurodermatitis /
atopic dermatitis - psoriasis - cradle cap and other conditions.
Lyfetec, Inc. will be re-testing with the new additives for the
Lyfetec Bio-Skin line which will be marketed as a treatment
lotion-shampoo and soap while entering Stage I of FDA new clinical
trials to support and verify its CE and FDA documentation with the
prior products which treats many types of skin diseases and some
skin cancers.
Lyfetec plans to complete the exact FDA study which had trails
in the U.S. and Europe.
Mr. Mellone, the company's President, said: "An important new
focus here, is to establish a new marketing approach, direct to
consumer, hospitals and doctors, such that families and individuals
can become more connected to their health and obtain the identify
of major illness at the earliest possible stage. These products we
have been in negotiations with for month, visit www.boi-skin.us. We
are also closing other products in the weeks to come that we have
been working on since last year."
Safe Harbor Provision
This news release includes forward-looking statements, including
with respect to the future level of business for the parties. These
statements are necessarily subject to risk and uncertainty. Actual
results could differ materially from those projected in these
forward-looking statements as a result of certain risk factors that
could cause results to differ materially from estimated results.
Management cautions that all statements as to future results of
operations are necessarily subject to risks, uncertainties and
events that may be beyond the control of Macada Holding, Inc. and
no assurance can be given that such results will be achieved.
Potential risks and uncertainties include, but are not limited to,
the ability to procure, properly price, retain and successfully
complete projects, the availability of technical personnel, changes
in technology and competition.
Contact: Ron Ritter 954-782-2056
KMA (CE) (USOTC:MCDA)
Historical Stock Chart
From Aug 2024 to Sep 2024
KMA (CE) (USOTC:MCDA)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about KMA Holdings Inc (CE) (OTCMarkets): 0 recent articles
More Macada Holding, Inc. News Articles